|

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

RECRUITINGSponsored by Seung-Jung Park
Actively Recruiting
SponsorSeung-Jung Park
Started2003-01
Est. completion2030-10
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT01788592

Summary

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* coronary disease amenable to percutaneous coronary intervention (PCI)
* no clinical and lesion limitations

Exclusion Criteria:

* patients with a mixture of several drug eluting stents
* terminal illness with life expectancy less than 1 year
* patients with cardiogenic shock

Conditions2

Coronary Artery DiseaseHeart Disease

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.